Cargando…

Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy

The potential therapeutic effects of agonistic analogs of growth hormone-releasing hormone (GHRH) and their mechanism of action were investigated in diabetic retinopathy (DR). Streptozotocin-induced diabetic rats (STZ-rats) were treated with 15 μg/kg GHRH agonist, MR-409, or GHRH antagonist, MIA-602...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thounaojam, Menaka C., Powell, Folami L., Patel, Sagar, Gutsaeva, Diana R., Tawfik, Amany, Smith, Sylvia B., Nussbaum, Julian, Block, Norman L., Martin, Pamela M., Schally, Andrew V., Bartoli, Manuela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2017
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740669/ https://www.ncbi.nlm.nih.gov/pubmed/29180438 http://dx.doi.org/10.1073/pnas.1718592114

Ejemplares similares

Monosodium Urate Contributes to Retinal Inflammation and Progression of Diabetic Retinopathy
por: Thounaojam, Menaka C., et al.
Publicado: (2019)

Growth hormone-releasing hormone (GHRH) and its agonists inhibit hepatic and tumoral secretion of IGF-1
por: Cui, Tengjiao, et al.
Publicado: (2018)

STAT3-mediated activation of miR-21 is involved in down-regulation of TIMP3 and neovascularization in the ischemic retina
por: Gutsaeva, Diana R., et al.
Publicado: (2017)

Role of Endothelial ADAM17 in Early Vascular Changes Associated with Diabetic Retinopathy
por: Shalaby, Lamiaa, et al.
Publicado: (2020)

Inhibition of HDAC6 Attenuates Diabetes-Induced Retinal Redox Imbalance and Microangiopathy
por: Abouhish, Hossameldin, et al.
Publicado: (2020)

Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways
por: Cui, Tengjiao, et al.
Publicado: (2016)

MicroRNA-34a (miR-34a) Mediates Retinal Endothelial Cell Premature Senescence through Mitochondrial Dysfunction and Loss of Antioxidant Activities
por: Thounaojam, Menaka C., et al.
Publicado: (2019)

Inhibiting microRNA-144 potentiates Nrf2-dependent antioxidant signaling in RPE and protects against oxidative stress-induced outer retinal degeneration
por: Jadeja, Ravirajsinh N., et al.
Publicado: (2019)

Ursodeoxycholic Acid Halts Pathological Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy
por: Thounaojam, Menaka C., et al.
Publicado: (2020)

Inactivation of Endothelial ADAM17 Reduces Retinal Ischemia-Reperfusion Induced Neuronal and Vascular Damage
por: Gutsaeva, Diana R, et al.
Publicado: (2020)

SAT-603 Growth Hormone-Releasing Hormone (GHRH) Antagonists Stimulate Feeding in Mice
por: Leone, Sheila, et al.
Publicado: (2020)

Tumorigenic transformation of human prostatic epithelial cell line RWPE‐1 by growth hormone‐releasing hormone (GHRH)
por: Muñoz‐Moreno, Laura, et al.
Publicado: (2022)

Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway
por: Guo, Jian, et al.
Publicado: (2010)

Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma
por: Villanova, Tania, et al.
Publicado: (2019)

Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease
por: Jaszberenyi, Miklos, et al.
Publicado: (2012)

Loss of NAMPT in aging retinal pigment epithelium reduces NAD(+) availability and promotes cellular senescence
por: Jadeja, Ravirajsinh N., et al.
Publicado: (2018)

P53, GHRH, inflammation and cancer
por: Barabutis, Nektarios, et al.
Publicado: (2018)

Effects of GHRH Deficiency and GHRH Antagonism on Emotional Disorders in Mice
por: Recinella, Lucia, et al.
Publicado: (2023)

Growth hormone-releasing hormone (GHRH) polymorphisms associated with carcass traits of meat in Korean cattle
por: Cheong, Hyun Sub, et al.
Publicado: (2006)

SUN-117 Growth Hormone-Releasing Hormone (GHRH) Deficiency Promotes Inflammation Associated Carcinogenesis
por: Recinella, PharmD, Lucia, et al.
Publicado: (2020)

MicroRNA-34a and vascular senescence in diabetes
por: Thounaojam, Menaka C., et al.
Publicado: (2019)

Synthesis and characterization of novel ssDNA X-aptamers targeting Growth Hormone Releasing Hormone (GHRH)
por: Ayhan-Sahin, Burcu, et al.
Publicado: (2022)

Metastatic Pancreatic Neuroendocrine Tumor that Progressed to Ectopic Adrenocorticotropic Hormone (ACTH) Syndrome with Growth Hormone-releasing Hormone (GHRH) Production
por: Tadokoro, Rie, et al.
Publicado: (2016)

An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer
por: Rick, Ferenc G, et al.
Publicado: (2013)

Protective effect of Growth Hormone-Releasing Hormone agonist in bacterial toxin-induced pulmonary barrier dysfunction
por: Czikora, Istvan, et al.
Publicado: (2014)

Growth Hormone–Releasing Hormone Agonists Reduce Myocardial Infarct Scar in Swine With Subacute Ischemic Cardiomyopathy
por: Bagno, Luiza L., et al.
Publicado: (2015)

The Application of GHRH Antagonist as a Treatment for Resistant APL
por: Chale, Ravinder S., et al.
Publicado: (2023)

Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers
por: Perez, Roberto, et al.
Publicado: (2012)

New therapies for relapsed castration-resistant prostate cancer based on peptide analogs of hypothalamic hormones
por: Schally, Andrew V, et al.
Publicado: (2015)

Implications of NAD(+) Metabolism in the Aging Retina and Retinal Degeneration
por: Jadeja, Ravirajsinh N., et al.
Publicado: (2020)

Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone
por: Jaszberenyi, Miklos, et al.
Publicado: (2013)

pNET co-secreting GHRH and calcitonin: ex vivo hormonal studies in human pituitary cells
por: Zornitzki, Taiba, et al.
Publicado: (2016)

Targeted cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), AEZS-108 (AN-152), inhibits the growth of DU-145 human castration-resistant prostate cancer in vivo and in vitro through elevating p21 and ROS levels
por: Popovics, Petra, et al.
Publicado: (2014)

SUN-930 A Case of Acromegaly Secondary to Ectopic Growth Hormone-Releasing Hormone (GHRH) Secretion from a Bronchial Neuroendocrine Tumour
por: Bahrami, Jasmine, et al.
Publicado: (2020)

Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer
por: Muñoz-Moreno, Laura, et al.
Publicado: (2016)

Growth hormone-releasing hormone agonist attenuates vascular calcification in diabetic db/db mice
por: Ren, Hao-Lin, et al.
Publicado: (2023)

Agonist of growth hormone-releasing hormone improves the disease features of spinal muscular atrophy mice
por: Boido, Marina, et al.
Publicado: (2023)

GHRH-antagonists in TNBC
por: Engel, Jörg B.
Publicado: (2015)

Homocysteine: A Potential Biomarker for Diabetic Retinopathy
por: Tawfik, Amany, et al.
Publicado: (2019)

Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma
por: Treszl, Andrea, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qod25f9dng23hl75n7nresvv2u